Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease:LEADe

Autoria(s): Feldman, H H; Doody, R S; Kivipelto, M; Sparks, D L; Waters, D D; Jones, R W; Schwam, E; Schindler, R; Hey-Hadavi, J; DeMicco, D A; Breazna, A; LEADe Investigators; Passmore, Peter
Data(s)

01/03/2010
Resumo

There is some evidence that statins may have a protective and symptomatic benefit in Alzheimer disease (AD). The LEADe study is a randomized controlled trial (RCT) evaluating the efficacy and safety of atorvastatin in patients with mild to moderate AD.
Identificador

http://pure.qub.ac.uk/portal/en/publications/randomized-controlled-trial-of-atorvastatin-in-mild-to-moderate-alzheimer-disease(55b91187-8b4a-4973-acd9-ee73fe6f9081).html

http://dx.doi.org/10.1212/WNL.0b013e3181d6476a
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Feldman , H H , Doody , R S , Kivipelto , M , Sparks , D L , Waters , D D , Jones , R W , Schwam , E , Schindler , R , Hey-Hadavi , J , DeMicco , D A , Breazna , A , LEADe Investigators & Passmore , P 2010 , ' Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease : LEADe ' Neurology , vol 74 , no. 12 , pp. 956-64 . DOI: 10.1212/WNL.0b013e3181d6476a
Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2728 #Clinical Neurology
Tipo

article
Acesso ao item digital